Evaluating Clinical Biomarkers for Testing Therapeutics in Patients
Time: 8:45 am
day: Day Two
Details:
- Understanding the value of novel clinical biomarkers and candidate endpoints for evaluating novel therapeutics
- Understanding how to make technical evaluations, and what data is needed to support their qualification and validation
- Understanding the expectations from regulatory authorities and clinicians in this field
